These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2829032)
1. Folate and antifolate cell binding and accumulation at physiologic folate concentrations. Kamen BA NCI Monogr; 1987; (5):37-9. PubMed ID: 2829032 [TBL] [Abstract][Full Text] [Related]
2. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells. Henderson GB; Strauss BP Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724 [TBL] [Abstract][Full Text] [Related]
4. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633 [TBL] [Abstract][Full Text] [Related]
5. Expression of a folate binding protein in L1210 cells grown in low folate medium. Jansen G; Kathmann I; Rademaker BC; Braakhuis BJ; Westerhof GR; Rijksen G; Schornagel JH Cancer Res; 1989 Apr; 49(8):1959-63. PubMed ID: 2702638 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier. Wang Y; Zhao R; Goldman ID Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Zhao R; Babani S; Gao F; Liu L; Goldman ID Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762 [TBL] [Abstract][Full Text] [Related]
8. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity. Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo. Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461 [TBL] [Abstract][Full Text] [Related]
10. Role of membrane-associated folate binding protein in the cytotoxicity of antifolates in KB, IGROV1, and L1210A cells. Schultz RM; Andis SL; Shackelford KA; Gates SB; Ratnam M; Mendelsohn LG; Shih C; Grindey GB Oncol Res; 1995; 7(2):97-102. PubMed ID: 7579732 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Sierra EE; Goldman ID Semin Oncol; 1999 Apr; 26(2 Suppl 6):11-23. PubMed ID: 10598550 [TBL] [Abstract][Full Text] [Related]
12. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier. Zhao R; Chattopadhyay S; Hanscom M; Goldman ID Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659 [TBL] [Abstract][Full Text] [Related]
13. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions. Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors. Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950 [TBL] [Abstract][Full Text] [Related]
15. Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells. Chattopadhyay S; Wang Y; Zhao R; Goldman ID Clin Cancer Res; 2004 Dec; 10(23):7986-93. PubMed ID: 15585634 [TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated folate uptake is positively regulated by disruption of the actin cytoskeleton. Lewis CM; Smith AK; Kamen BA Cancer Res; 1998 Jul; 58(14):2952-6. PubMed ID: 9679952 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701 [TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated folate accumulation is regulated by the cellular folate content. Kamen BA; Capdevila A Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5983-7. PubMed ID: 3461471 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier. Zhao R; Gao F; Babani S; Goldman ID Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817 [TBL] [Abstract][Full Text] [Related]
20. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Nakashima-Matsushita N; Homma T; Yu S; Matsuda T; Sunahara N; Nakamura T; Tsukano M; Ratnam M; Matsuyama T Arthritis Rheum; 1999 Aug; 42(8):1609-16. PubMed ID: 10446858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]